Filed by OTC Filings Inc. - www.otcedgar.com - 1-866-832-FILE(3453) - Cannabis Science, Inc. - Exhibit 10.1

  
 DEBT SETTLEMENT AGREEMENT
 

 THIS AGREEMENT is dated for reference the 5th day of November 2013.
 

 BETWEEN:
 

 Cannabis Science, Inc., a company incorporated under the laws of Nevada and having an office at 6946 N Academy Blvd., Suite B 254 Colorado Springs, CO 80918
 

 (the “Company”)
 

 OF THE FIRST PART
 

 AND:
 

 Intrinsic Venture Corp., a company incorporated under the laws of British Columbia, having an address at 900-555 Burrard St., Vancouver, BC V7X 1M8
 

 (the “Creditor”)
 

 OF THE SECOND PART
 

 WHEREAS:
 

 A.
 The Company is indebted to the Creditor in the total amount of US $9,000.00 (the “Debt”) as at November 5, 2013;
 

 B.
 The Company wishes to settle the Debt by issuing to the Creditor, or its assigns, shares of common stock of the Company and the Creditor is prepared to accept the shares in full satisfaction of the Debt.
 

 NOW THEREFORE THIS AGREEMENT WITNESSES that, in consideration of the premises and of the covenants and agreements set out in this Agreement, the parties agree as follows:
 

 1.
 ACKNOWLEDGMENT OF DEBT
 

 1.1
 The Company acknowledges and agrees that it is indebted to the Creditor in the amount of the Debt.
 

 1.2
 The Debt was recorded on the books of the Company on January 27, 2012.
  
 2.
 ISSUANCE OF SHARES
 

 2.1 
 The Company agrees to issue to the Creditor and the Creditor agrees to accept 9,000,000 shares of common stock of the Company (the “Shares”) at a deemed price of US $0.001 per Share as full and final payment of the Debt.
 

 2.2 
 The Creditor agrees that the Debt will be fully satisfied and extinguished when the Company delivers the Shares to the Creditor, and subject only to the issuance of the Shares, the Creditor releases and forever discharges the Company, its subsidiaries and their respective directors, officers, and employees from and against any and all claims, actions, obligations, and damages whatsoever which the Creditor may have against any of them relating to the Debt.  This release will be operative from and after the date of completion of the transaction contemplated by this Agreement and will be effective without the delivery of any further release or other documents by the Creditor to the Company.
  
  	 1

	               



 

 3.
 REPRESENTATIONS OF CREDITOR
 

 The Creditor represents, warrants and acknowledges to the Company that:
 

 (a) 
 the Debt constitutes the entire outstanding indebtedness of the Company to the Creditor as at November 5, 2013, including principal, interest to the date hereof and costs;
 

 (b) 
 the Creditor has not conveyed, transferred or assigned any portion of the Debt to any third party, and has full right, power and authority to enter into this Agreement and to accept the Shares in full and final satisfaction of the Debt;
 

 (c) 
 no third party has any right to payment of all or any portion of the Debt;
  
 (d) 
 the Creditor has no claims or potential claims against the Company on account of any matter whatsoever, other than the Debt;
  
 (e) 
 if the Creditor is a corporation or legal entity other than an individual, all necessary corporate or other action has been taken by the Creditor to approve this Agreement;
 

 (f)
  the Company is relying on exemptions from registration and prospectus requirements of applicable securities laws in the United States to issue the Shares to the Creditor;
 

 (g) 
 the Creditor is not acquiring the Shares as a result of any material information that the Company has not generally disclosed to the public; and
 

 (h)
 the Shares will be subject to resale restrictions as required by applicable securities law and the Creditor will seek its own independent legal advice regarding such resale restrictions imposed on the Shares.The Company’s obligation to complete the transactions contemplated hereby is subject to the foregoing representations and warranties being true and correct at the date of this Agreement and at the time of closing.  Such representations and warranties will survive the closing of the transactions contemplated hereby and will continue in full force and effect for the benefit of the Company for a period of five years from the date of issuance of the Shares to the Creditor.  The Creditor will indemnify the Company from and against any and all claims, damages, losses and costs arising from such representations ad warranties being incorrect or breached.
 

 4.
 GENERAL PROVISIONS
 

 4.1 
 Time will be of the essence of this Agreement.
 

 4.2 
 The Company and the Creditor will sign all other documents and do all other things reasonably necessary to carry out this Agreement.
 

 4.3 
 The provisions contained in this Agreement constitute the entire agreement between the parties and supersede all previous understandings, communications, representations, and agreements, whether written or verbal, between the parties regarding the subject matter of this Agreement.
 

 4.4 
 All dollar amounts referred to in this Agreement are expressed in United States currency, unless otherwise indicated.
 

 4.5 
 This Agreement will enure to the benefit of and be binding on each of the parties and their respective heirs, executors, administrators, successors, and assigns.
 

 4.6 
 This Agreement may be signed in counterparts, both of which will constitute one agreement.
 

 4.7 
 This Agreement supersedes and replaces any prior agreements between the parties concerning the subject matter hereof.
 

 IN WITNESS WHEREOF the parties have signed this Agreement as of the date written on the first page of this Agreement.
 

 

 CANNABIS SCIENCE, INC
 

 Per: /s/ Dr. Robert Melamede
 _________________________________
 Dr. Robert Melamede, Director and CEO
  
 

 INTRINSIC VENTURE CORP.
 

 Per: /s /J. Scott Munro 
 _________________________________
 J. Scott Munro, President
 

 


 
 	 2

	               



 DEBT SETTLEMENT AGREEMENT
 

 THIS AGREEMENT is dated for reference the 6th day of November 2013.
 

 BETWEEN:
 

 Cannabis Science, Inc., a company incorporated under the laws of Nevada and having an office at 6946 N Academy Blvd., Suite B 254 Colorado Springs, CO 80918
 

 (the “Company”)
 

 OF THE FIRST PART
 

 AND:
 

 Intrinsic Venture Corp., a company incorporated under the laws of British Columbia, having an address at 900-555 Burrard St., Vancouver, BC V7X 1M8
 

 (the “Creditor”)
 

 OF THE SECOND PART
 

 WHEREAS:
 

 A.
 The Company is indebted to the Creditor in the total amount of US $9,000.00 (the “Debt”) as at November 6, 2013;
 

 B.
 The Company wishes to settle the Debt by issuing to the Creditor, or its assigns, shares of common stock of the Company and the Creditor is prepared to accept the shares in full satisfaction of the Debt.
 

 NOW THEREFORE THIS AGREEMENT WITNESSES that, in consideration of the premises and of the covenants and agreements set out in this Agreement, the parties agree as follows:
 

 1.
 ACKNOWLEDGMENT OF DEBT
 

 1.1
 The Company acknowledges and agrees that it is indebted to the Creditor in the amount of the Debt.
 

 1.2
 The Debt was recorded on the books of the Company on January 27, 2012.
  
 2.
 ISSUANCE OF SHARES
 

 2.1 
 The Company agrees to issue to the Creditor and the Creditor agrees to accept 9,000,000 shares of common stock of the Company (the “Shares”) at a deemed price of US $0.001 per Share as full and final payment of the Debt.
 

 2.2 
 The Creditor agrees that the Debt will be fully satisfied and extinguished when the Company delivers the Shares to the Creditor, and subject only to the issuance of the Shares, the Creditor releases and forever discharges the Company, its subsidiaries and their respective directors, officers, and employees from and against any and all claims, actions, obligations, and damages whatsoever which the Creditor may have against any of them relating to the Debt.  This release will be operative from and after the date of completion of the transaction contemplated by this Agreement and will be effective without the delivery of any further release or other documents by the Creditor to the Company.
  
  	 3

	               



 

 3.
 REPRESENTATIONS OF CREDITOR
 

 The Creditor represents, warrants and acknowledges to the Company that:
 

 (a) 
 the Debt constitutes the entire outstanding indebtedness of the Company to the Creditor as at November 6, 2013, including principal, interest to the date hereof and costs;
 

 (b) 
 the Creditor has not conveyed, transferred or assigned any portion of the Debt to any third party, and has full right, power and authority to enter into this Agreement and to accept the Shares in full and final satisfaction of the Debt;
 

 (c) 
 no third party has any right to payment of all or any portion of the Debt;
  
 (d) 
 the Creditor has no claims or potential claims against the Company on account of any matter whatsoever, other than the Debt;
  
 (e) 
 if the Creditor is a corporation or legal entity other than an individual, all necessary corporate or other action has been taken by the Creditor to approve this Agreement;
 

 (f)
  the Company is relying on exemptions from registration and prospectus requirements of applicable securities laws in the United States to issue the Shares to the Creditor;
 

 (g) 
 the Creditor is not acquiring the Shares as a result of any material information that the Company has not generally disclosed to the public; and
 

 (h)
  the Shares will be subject to resale restrictions as required by applicable securities law and the Creditor will seek its own independent legal advice regarding such resale restrictions imposed on the Shares.The Company’s obligation to complete the transactions contemplated hereby is subject to the foregoing representations and warranties being true and correct at the date of this Agreement and at the time of closing.  Such representations and warranties will survive the closing of the transactions contemplated hereby and will continue in full force and effect for the benefit of the Company for a period of five years from the date of issuance of the Shares to the Creditor.  The Creditor will indemnify the Company from and against any and all claims, damages, losses and costs arising from such representations ad warranties being incorrect or breached.
 

 4.
 GENERAL PROVISIONS
 

 4.1 
 Time will be of the essence of this Agreement.
 

 4.2 
 The Company and the Creditor will sign all other documents and do all other things reasonably necessary to carry out this Agreement.
 

 4.3 
 The provisions contained in this Agreement constitute the entire agreement between the parties and supersede all previous understandings, communications, representations, and agreements, whether written or verbal, between the parties regarding the subject matter of this Agreement.
 

 4.4 
 All dollar amounts referred to in this Agreement are expressed in United States currency, unless otherwise indicated.
 

 4.5 
 This Agreement will enure to the benefit of and be binding on each of the parties and their respective heirs, executors, administrators, successors, and assigns.
 

 4.6 
 This Agreement may be signed in counterparts, both of which will constitute one agreement.
 

 4.7 
 This Agreement supersedes and replaces any prior agreements between the parties concerning the subject matter hereof.
 

 IN WITNESS WHEREOF the parties have signed this Agreement as of the date written on the first page of this Agreement.
 

 

 CANNABIS SCIENCE, INC
 

 Per: /s/ Dr. Robert Melamede
 _________________________________
 Dr. Robert Melamede, Director and CEO
 

  
 INTRINSIC VENTURE CORP.
 

 Per: /s/ J. Scott Munro 
 _________________________________
 J. Scott Munro, President
  
  	 4

	               



  
 DEBT SETTLEMENT AGREEMENT
 

 THIS AGREEMENT is dated for reference the 25th day of November 2013.
 

 BETWEEN:
 

 Cannabis Science, Inc., a company incorporated under the laws of Nevada and having an office at 6946 N Academy Blvd., Suite B 254 Colorado Springs, CO 80918
 

 (the “Company”)
 

 OF THE FIRST PART
 

 AND:
 

 Christopher P. Meenan, and individual with an address of 2 Round Hill Terrace, Kinnelon, NJ 07405
 

 (the “Creditor”)
 

 OF THE SECOND PART
 

 WHEREAS:
 

 A.
 The Company is indebted to the Creditor in the total amount of US $24,000.00 (the “Debt”) as at November 25, 2013;
 

 B.
 The Company wishes to settle the Debt and commitments under an October 26, 2012 Management Agreement (“Management Agreement”) by issuing to the Creditor shares of Rule 144 common stock of the Company and the Creditor is prepared to accept the shares in full satisfaction of the Debt.
 

 NOW THEREFORE THIS AGREEMENT WITNESSES that, in consideration of the premises and of the covenants and agreements set out in this Agreement, the parties agree as follows:
 

 1.
 ACKNOWLEDGMENT OF DEBT
 

 1.1
 The Company acknowledges and agrees that it is indebted to the Creditor in the amount of the Debt.
 

 1.2
 The Debt was recorded on the books of the Company on February 26, March 26, April 26, May 26, June 26, and July 26, 2013 at a rate of $4,000 per month earned under the Management Agreement.
  
 2.
 ISSUANCE OF SHARES
 

 2.1 
 The Company agrees to issue to the Creditor and the Creditor agrees to accept 1,500,000 shares of restricted common stock, restricted under Rule 144 of the U.S. Securities and Exchange Act of 1934 (“Rule 144”), of the Company (the “Shares”) at a deemed price of US $0.016 per Share as full and final payment of the Debt and amounts due under the Management Agreement.  The Company will provide necessary stock clearance and release instructions to its transfer agent, Securities Stock Transfer, Inc., 
 after the applicable six-month hold period under Rule 144 has been fulfilled regarding the Shares.  The Company shall not take any steps to adversely delay or hold the Shares from clearance with its transfer agent upon the Creditor meeting the requirements under Rule 144.
 

 2.2 
 The Creditor agrees that the Debt and any further commitments under his Management Agreement will be fully satisfied and extinguished when the Company delivers the Shares to the Creditor, and subject only to the issuance of the Shares, the Creditor releases and forever discharges the Company, its subsidiaries and their respective directors, officers, and employees from and against any and all claims, actions, obligations, and damages whatsoever which the Creditor may have against any of them relating to the Debt or the Management Agreement.  This release will be operative from and after the date of completion of the transaction contemplated by this Agreement and will be effective without the delivery of any further release or other documents by the Creditor to the Company.
  
  	 5

	               



 

 3.
 REPRESENTATIONS OF CREDITOR
 

 The Creditor represents, warrants and acknowledges to the Company that:
 

 (a) 
 the Debt constitutes the entire outstanding indebtedness of the Company to the Creditor under the Management Agreement as at November 25, 2013, including principal, interest to the date hereof and costs with the Creditor acknowledging that management fees ceased accruing on July 26, 2013;
 

 (b) 
 the Creditor has not conveyed, transferred or assigned any portion of the Debt to any third party, and has full right, power and authority to enter into this Agreement and to accept the Shares in full and final satisfaction of the Debt;
 

 (c) 
 no third party has any right to payment of all or any portion of the Debt;
  
 (d) 
 the Creditor has no claims or potential claims against the Company on account of any matter whatsoever, other than the Debt;
  
 (e) 
 if the Creditor is a corporation or legal entity other than an individual, all necessary corporate or other action has been taken by the Creditor to approve this Agreement;
 

 (f)
  the Company is relying on exemptions from registration and prospectus requirements of applicable securities laws in the United States to issue the Shares to the Creditor;
 

 (g) 
 the Creditor is not acquiring the Shares as a result of any material information that the Company has not generally disclosed to the public; and
 

 (h)
  the Shares will be subject to resale restrictions as required by applicable securities law and the Creditor will seek its own independent legal advice regarding such resale restrictions imposed on the Shares. The Company’s obligation to complete the transactions contemplated hereby is subject to the foregoing representations and warranties being true and correct at the date of this Agreement and at the time of closing.  Such representations and warranties will survive the closing of the transactions contemplated hereby and will continue in full force and effect for the benefit of the Company for a period of five years from the date of issuance of the Shares to the Creditor.  The Creditor will indemnify the Company from and against any and all claims, damages, losses and costs arising from such representations ad warranties being incorrect or breached.
 

 4.
 GENERAL PROVISIONS
 

 4.1 
 Time will be of the essence of this Agreement.
 

 4.2 
 The Company and the Creditor will sign all other documents and do all other things reasonably necessary to carry out this Agreement.
 

 4.3 
 The provisions contained in this Agreement constitute the entire agreement between the parties and supersede all previous understandings, communications, representations, and agreements, whether written or verbal, between the parties regarding the subject matter of this Agreement.
 

 4.4 
 All dollar amounts referred to in this Agreement are expressed in United States currency, unless otherwise indicated.
 

 4.5 
 This Agreement will enure to the benefit of and be binding on each of the parties and their respective heirs, executors, administrators, successors, and assigns.
 

 4.6 
 This Agreement may be signed in counterparts, both of which will constitute one agreement.
 

 4.7 
 This Agreement supersedes and replaces any prior agreements between the parties concerning the subject matter hereof.
 

 IN WITNESS WHEREOF the parties have signed this Agreement as of the date written on the first page of this Agreement.
 

 

 CANNABIS SCIENCE, INC
 

 Per: /s/ Dr. Robert Melamede
 _____________________________________
 Dr. Robert Melamede, Director and President
 

 

 CREDITOR
 

 Per: /s/ Christopher P. Meenan
 _________________________________
 Christopher P. Meenan
 

 
 	 6